Allosteric activation of the SPRTN protease by ubiquitin maintains genome stability
Abstract
The DNA-dependent protease SPRTN maintains genome stability by degrading toxic DNA-protein crosslinks (DPCs). To understand how SPRTNs promiscuous protease activity is confined to the cleavage of crosslinked proteins, we reconstitute the repair of DPCs including their modification with SUMO and ubiquitin chains, using recombinant human proteins. We discover that DPC ubiquitylation strongly activates SPRTN independently of SPRTNs known ubiquitin-binding domains. Using protein structure prediction, MD simulations and NMR spectroscopy we reveal that ubiquitin binds to an interface at the back of SPRTNs protease domain, promoting an active conformation. Replacing key interfacial residues prevents ubiquitin-dependent activation of SPRTN, which leads to genomic instability and cell cycle defects in cells expressing hypomorphic SPRTN variants that cause premature aging and liver cancer in Ruijs-Aalfs syndrome patients. Collectively, our results demonstrate that SPRTN activation is coupled to the modification of the crosslinked protein, explaining how specificity is achieved during DPC repair.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper addresses the mechanism by which the SPRTN protease maintains genome stability, which is a critical aspect of cellular aging and the prevention of age-related diseases such as cancer. By elucidating the role of ubiquitin in activating SPRTN and its implications for genomic stability, the research contributes to understanding the molecular underpinnings of aging processes. However, while the findings are solid and contribute to the field, they do not represent a major breakthrough or transformative insight, hence the moderate impact score.
Author of this paper? Send a correction.